This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Increased vascular permeability

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

After blood flow has initially increased, there comes a period of increased vascular permeability resulting in exudation of plasma proteins and tissue oedema. The normal balance of capillary oncotic and hydrostatic pressure is disrupted.

For mild injury, released cytokines such as histamine and bradykinin act on venules to cause endothelial cell contraction, thus opening gaps between cells. On an ultrastructural level, these mediators initially cause a rise in inositol triphosphate and then intercellular released cytoplasmic calcium which peaks after 30 seconds. Later, extracellular calcium leaks into the cell over a prolonged period. Calcium causes the contraction of actin-myosin filaments. This leads to the opening of intercellular gaps between cells by up to 1 micrometre.

More severe injury may result in a simple mechanical breach of the endothelial wall. Other cytokines involved with increasing vascular pemeability include:

  • complement components C3a and C5a
  • leukotrienes C, D and E
  • platelet activating factor

A late and extended leak of plasma may occur in certain circumstances e.g. thermal injuries such as sunburn, radiation exposure such as radiography, and in type IV hypersensitivity reactions.


Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.